Document ID: chunk:federal_register_of_legislation:F2020C01070:clause:3_6
Version: federal_register_of_legislation:F2020C01070
Segment Type: clause
Provision Reference: sch 3 cl 6
Character Range: 11000–11775

6  Application
 (1) Subject to subsection (2), this instrument applies to therapeutic goods that are intended for oral administration, and manufactured in the following dosage forms:
 (a) tablet;
 (b) capsule; and
 (c) pill.
  Note: Part 3 and Schedule 3 of this instrument, which sets out requirements in relation to pills, commences on 31 March 2021 in accordance with section 2.
 (2) This instrument does not apply to therapeutic goods that are:
 (a) a radiopharmaceutical;
 (b) an export only medicine;
 (c) exempt under section 18 or 18A of the Act;
 (d) the subject of an approval or authority under section 19 of the Act; or
 (e) the subject of an approval under section 19A of the Act.

Part 2—Tablets and capsules

Division 1Requirements for tablets and capsules